Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
31.55
+1.55 (5.17%)
At close: Aug 13, 2025, 4:00 PM
31.25
-0.30 (-0.95%)
After-hours: Aug 13, 2025, 6:54 PM EDT
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $4.10 billion as of August 13, 2025. Its market cap has decreased by -54.58% in one year.
Market Cap
4.10B
Enterprise Value
2.52B
1-Year Change
-54.58%
Ranking
Category
Stock Price
$31.55
Market Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from $1.38B to $4.10B, an increase of 196.81%. That is a compound annual growth rate of 23.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 4.10B | -59.85% |
| Dec 31, 2024 | 10.20B | 70.74% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.58% |
| Dec 31, 2021 | 1.26B | -7.24% |
| Dec 31, 2020 | 1.35B | -1.90% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |